← Browse by Condition
Medical Condition
radiotherapy
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2
NCT06249321 Phase 2
Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
Enrollment
30 pts
Location
China
Sponsor
Fudan University
NCT04684186
Recruiting
Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer
Enrollment
60 pts
Location
Switzerland
Sponsor
Centre Hospitalier Universitai...
NCT06389422 Phase 2
Recruiting
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Enrollment
30 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT06688760
Recruiting
Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma
Enrollment
86 pts
Location
China
Sponsor
Ming-Yuan Chen
NCT05554276 Phase 2
Recruiting
Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer
Enrollment
36 pts
Location
China
Sponsor
Shanghai Jiao Tong University ...
NCT07071103 Phase 2
Recruiting
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Enrollment
48 pts
Location
China
Sponsor
Chuangzhen Chen
NCT06256705
Recruiting
Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
Enrollment
80 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT07230639 Phase 2
Recruiting
Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial
Enrollment
52 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
NCT06356584 Phase 2
Recruiting
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases
Enrollment
62 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...
NCT06433817
Recruiting
Spectral CT in Radiotherapy for Cervical Cancer
Enrollment
150 pts
Location
China
Sponsor
Peking Union Medical College H...